B cells as biomarkers: predicting immune checkpoint therapy adverse events. [electronic resource]
- The Journal of clinical investigation 02 2018
- 577-579 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Comment
1558-8238
10.1172/JCI99036 doi
Autoimmunity B-Lymphocytes Biomarkers Humans Immunotherapy Programmed Cell Death 1 Receptor